Scientists have uncovered a hidden driver of ovarian cancer—high-risk mesenchymal stem cells lurking in the fallopian tubes.

An international research team led by a Boston College professor has uncovered a drug and diet pairing that could fight a deadly brain cancer The international team combined a calorie-restricted diet ...

For patients with distant-stage cancers, there was an increase in early palliative care (PC) billing from 2010 to 2019, but the level remained low, according to a study published in the Journal of ...

Transcription is the process by which an RNA polymerase synthesizes ribonucleic acid (RNA) using deoxyribonucleic acid (DNA) as a template. Understanding how RNA folds into functional structures ...

The disease, which accounts for nearly half (49%) of all brain tumors, has an extremely low survival rate, with most patients living only about 12 months after diagnosis. For this reason, scientists ...

Abnormalities in these systems can lead to tumor development, as evidenced by the upregulation of glutamate dehydrogenase (GDH) in colorectal cancer cells, which induces epithelial-mesenchymal ...

Abstract: The complex nature of brain tumors, characterized by their individual shapes, sizes, and locations, as well as the presence of indistinct boundaries, presents a challenging task for precise ...

Our kidneys’ main job is to filter our blood. Sometimes we develop masses (growths or tumors) inside our kidneys. Some of these growths are cancerous but many are not. You must have your mass checked ...

The goal of this study is to compare the effectiveness of adding an immunotherapy drug (retifanlimab) to the standard of care (radiation and chemotherapy) for people with glioblastoma (GBM) brain ...